Clinical Research Directory

Inclusion Criteria: * Between 30 and 60 years old. * Body mass index values will range from \>18.5 and \<29.9 kg/m2 * Subject agrees to maintain their existing dietary patterns throughout the study period. * Subject agrees to refrain from alcohol, caffeine, and strenuous exercise for 24 hours prior to each test day. * Is physically active, defined as at least 30 min of moderate exercise on at least 4 days a week. * Avoid consumption of pomegranate juice and avoid consumption of CoQ10, vitamin B3 and its precursors, L-carnitine, MK-4 * Subject is willing and able to comply with the study protocol. * Subject has given voluntary, written, informed consent to participate in the study. Exclusion Criteria: * BMI \<18.5 or \> 29.9 kg/m2 * Positive medical history and/or is currently being treated for some form of heart disease, cardiovascular disease, kidney disease, renal failure, or has dialysis performed on regular intervals, Type I or Type II diabetes (determined as fasting blood glucose \> 126 mg/dL), thyroid disease, liver disease or some form of clinically diagnosed hepatic impairment, immune disorder (i.e., HIV/AIDS), or neurological condition or disease. * Diagnosed with any affective disorder or other psychiatric disorder that required hospitalization in the prior year. * History of cancer (except localized skin cancer without metastases or in situ cervical cancer within 5 years prior to screening visit). * Participant has an abnormality or obstruction of the gastrointestinal tract precluding swallowing (e.g., dysphagia) and digestion (e.g., known intestinal malabsorption, celiac disease, inflammatory bowel disease, chronic pancreatitis, steatorrhea) * Genetic musculoskeletal and neurologic disorder known to affect skeletal muscle metabolism * Has donated blood in past 60 days * Diagnosed with or being treated for any endocrinological disorder and/or taking hormone boosting supplements (e.g. herbs) or hormone replacement therapy (prescribed/doctor ordered or not) * Had CoQ10 supplement in past 30 days. Had steroid medication one month before starting the study * Currently prescribed for the first time a statin drugs (i.e., Lipitor, Livalo, Crestor, Zocor, etc.) and/or a hypertension medication (i.e., Beta-blockers, ACE Inhibitors, Alpha blockers, - Vasodilators, etc.) within the past 6 months or has had their dosage or medication changed within the past 6 months * Current smoker (average of \> 1 pack per week within the past 3 months) or has quit within the past six months. This includes all forms of nicotine * Intake of any drugs (prescribed or over the counter) or dietary supplements that are known or are purported to impact energy expenditure or weight loss (caffeine doses \<300 mg/day is permissible) * Women with a history of hormone-related conditions such as endometriosis, fibroids, polycystic ovary syndrome * Women who are pregnant, planning to become pregnant, or lactating currently or within the past six months * Have a known sensitivity or allergy to any of the study products * History of alcohol or substance abuse in the 12 months prior to screening * Receipt or use of an investigational product in another research study within 30 days of beginning the study protocol * Has participated in other clinical trials focused on physical and muscle performance within the last year * They plan major changes in lifestyle (i.e., diet, dieting, exercise level, travel, etc.) during the study * Individuals who regularly compete as part of sanctioned athletic activities or those individuals who regularly train more than 360 minutes of exercise per week * Recent history (\<3 months) of exercise training or weight loss (\> 5%) * Any condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data